| Patents > Guidance, Tools, and Manuals > Classification > Class Schedule |
|
|
|
| Class Numbers & Titles | Class Numbers Only | USPC Index | International | HELP |
|
| You are viewing a USPC Schedule. |
|
| Class 424 | DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS |
| Click here for a printable version of this file | |
![[List of Pre Grant Publications for class 424 subclass 1.11]](../as.gif) | ![[List of Patents for class 424 subclass 1.11]](../ps.gif) | 1.11 | RADIONUCLIDE OR INTENDED RADIONUCLIDE CONTAINING; ADJUVANT OR CARRIER COMPOSITIONS; INTERMEDIATE OR PREPARATORY COMPOSITIONS |
| | 1.13 |  In aerosol, fine spray, effervescent, pressurized fluid, vapor or gas, or complete composition therefor |
| | 1.17 | Attached to or within viable or inviable whole micro-organism, cell, virus, fungus or specified sub-cellular structure thereof (e.g., platelet, red blood cell) |
| | 1.21 | Molecular bilayer structure (e.g., vesicle, liposome) |
| | 1.25 | Dissolving or eluting from solid or gel matrix (e.g., capsule, tablet) |
| | 1.29 | Coated, impregnated, or colloidal particulate (e.g., microcapsule, micro-sphere, micro-aggregate, macro-aggregate) |
| | 1.33 |  Delivery to active site involves particle dissolving, degrading, or otherwise releasing of radionuclide |
| | 1.37 | Radionuclide or intended radionuclide in an organic compound |
| | 1.49 | Attached to antibody or antibody fragment or immunoglobulin; derivative |
| | 1.53 | Attachment via an added element (e.g., bifunctional compound or coordinate, coupling agent, spacer compound, bridging compound, conjugated chelate) |
| | 1.57 | Attached to antigen or hapten; derivative thereof |
| | 1.61 | In an inorganic compound |
| | 1.65 | In an organic compound |
| | 1.69 | Attached to peptide or protein of 2+ amino acid units (e.g., dipeptide, folate, fibrinogen, transferrin, sp. enzymes); derivative thereof |
| | 1.73 | Attached to carbohydrate compound; derivative thereof (e.g., DNA, nucleotide, nucleoside, sugar, starch, tannin, saccharide, polysaccharide, cellulose, O-, N- and S-glycoside, vitamin B12) |
| | 1.77 | Phosphorus-containing organic compound |
| | 1.81 | Nonmetal radionuclide or intended radionuclide (e.g., carbon) |
| | 9.1 | IN VIVO DIAGNOSIS OR IN VIVO TESTING |
| | 9.2 | Testing efficacy or toxicity of a compound or composition (e.g., drug, vaccine, etc.) |
| | 9.3 | Magnetic imaging agent (e.g., NMR, MRI, MRS, etc.) |
| | 9.31 | Clay or zeolite containing |
| | 9.32 | Particle containing a transition, actinide, or lanthanide metal (e.g., hollow or solid particle, granule, etc.) |
| | 9.33 | Nitroxide or nitroxide containing |
| | 9.34 | Polypeptide attached to or complexed with the agent (e.g., protein, antibody, etc.) |
| | 9.35 | Carbohydrate or derivative thereof attached to or complexed with the agent |
| | 9.36 | Transition, actinide, or lanthanide metal containing |
| | 9.361 |  Heterocyclic compound is attached to or complexed with the metal |
| | 9.364 | Polyamino-polycarbonyl moiety attached to or complexed with the metal |
| | 9.37 | Imageable halogen containing |
| | 9.4 | X-ray contrast imaging agent (e.g., computed tomography, angiography, etc.) |
| | 9.41 | Barium containing |
| | 9.42 | Transition, actinide, or lanthanide metal containing |
| | 9.43 | Carbohydrate or derivative thereof attached to or complexed with the agent |
| | 9.44 | Hetero ring containing |
| | 9.45 | Halogenated benzene ring containing |
| | 9.451 | Two or more halogenated benzene rings in the same compound |
| | 9.452 |  Three or more amide groups are attached directly to the same benzene ring by nonionic bonding |
| | 9.453 | Carbonyl of a carboxylic acid or salt thereof attached directly to the benzene ring |
| | 9.454 | Three or more amide groups are attached directly to the same benzene ring by nonionic bonding |
| | 9.455 | Carbonyl of a carboxylic acid or salt thereof attached directly to the benzene ring |
| | 9.5 | Ultrasound contrast agent |
| | 9.51 | Liposome containing |
| | 9.52 | Stable gas bubbles containing or intentional solubilized gas containing |
| | 9.6 | Diagnostic or test agent produces in vivo fluorescence |
| | 9.7 | Diagnostic or test agent produces visible change in mouth |
| | 9.8 | Diagnostic or test agent produces visible change on skin |
| | 10.1 | IDENTIFICATION OR WARNING FEATURE |
| | 10.2 | Printed or embossed unitary dosage form |
| | 10.3 | Color or color change feature |
| | 10.31 | Combined with animal or insect repellant or insecticide (e.g., shark, fish, roach, etc.) |
| | 10.32 | Combined with ophthalmic or dentifrice preparation |
| | 10.4 | Taste or smell or chemical irritation to the eye, nose, or mouth feature |
| | 40 | COMBUSTIBLE OR CHEMICALLY REACTIVE TO PRODUCE A SMOKE, MIST OR AEROSOL |
| | 400 | PREPARATIONS CHARACTERIZED BY SPECIAL PHYSICAL FORM |
| | 401 | Cosmetic, antiperspirant, dentifrice |
| | 402 | Wearing apparel, fabric, or cloth |
| | 405 | Biocides; animal or insect repellents or attractants (e.g., disinfectants, pesticides, etc.) |
| | 406 | Ingredients for reducing the noxious effect of the active substances to organisms other than pest (e.g., toxicity reducing compositions, self-destructing compositions, etc.) |
| | 407 | Containing material to enhance the sticking of the active ingredients |
| | 408 | Capsule or pelleted or tablet |
| | 409 | Solid as carrier or diluent |
| | 422 | Implant or insert |
| | 423 | Surgical implant or material |
| | 427 | Ocular |
| | 430 | Vaginal, urethral, uterine |
| | 434 | Mucosal (e.g., nasal, etc.) |
| | 437 | Otic |
| | 438 | Specially adapted for ruminant animal |
| | 439 | Food or edible as carrier for pharmaceutical |
| | 443 | Web, sheet or filament bases; compositions of bandages; or dressings with incorporated medicaments |
| | 450 | Liposomes |
| | 451 | Capsules (e.g., of gelatin, of chocolate, etc.) |
| | 452 | With claimed designated perfecting feature in contents (e.g., excipient, lubricant, etc.) |
| | 453 | Telescoping two piece |
| | 455 | Containing emulsions, dispersions, or solutions |
| | 456 | Gelatin |
| | 457 | Sustained or differential release |
| | 463 | Coated capsules |
| | 464 | Tablets, lozenges, or pills |
| | 465 | With claimed perfecting feature in contents (e.g., excipient, lubricant, etc.) |
| | 466 | Effervescent |
| | 467 | Printed, embossed, grooved, or perforated |
| | 468 | Sustained or differential release type |
| | 469 | Discrete particles in supporting matrix |
| | 471 | Plural concentric cores |
| | 472 | Layered unitary dosage forms |
| | 474 | Coated pills or tablets |
| | 475 | Organic coatings |
| | 476 | Containing waxes, higher fatty acids, higher fatty alcohols, or derivatives thereof (e.g., chocolate) |
| | 477 | Containing proteins or derivatives thereof |
| | 479 | Containing polysaccharide (e.g., sugar, etc.) |
| | 481 | Containing natural gums or resins |
| | 482 | Containing solid synthetic polymers |
| | 483 | Ion-exchange resins |
| | 484 | Matrices |
| | 489 | Particulate form (e.g., powders, granules, beads, microcapsules, and pellets) |
| | 490 | Coated (e.g., microcapsules) |
| | 491 | Containing proteins and derivatives |
| | 493 | Containing polysaccharides (e.g., sugars) |
| | 496 | Containing natural gums/resins |
| | 497 | Containing solid synthetic polymers |
| | 498 | Containing waxes, higher fatty acids, higher fatty alcohols, or derivatives thereof |
| | 499 | Contains proteins or derivative or polysaccharides or derivative |
| | 500 | Contains natural gums and resins |
| | 501 | Contains solid synthetic resin |
| | 502 | Contains waxes, higher fatty acids, higher fatty alcohols |
| | 43 | EFFERVESCENT OR PRESSURIZED FLUID CONTAINING |
| | 48 | CHEWING GUM TYPE |
| | 49 | DENTIFRICES (INCLUDES MOUTH WASH) |
| | 50 | Ferment containing (e.g., enzymes, bacteria, etc.) |
| | 51 | Iodine or iodine compound containing |
| | 52 | Fluorine or fluorine compound containing |
| | 53 | Oxygen or chlorine releasing compound containing |
| | 54 | Ammonia, amine, or derivative thereof (e.g., urea, etc.) |
| | 55 | Hydroxy carboxylic acid or derivative thereof (e.g., methyl salicylate, etc.) |
| | 56 | Organic sulfate or sulfonate containing |
| | 57 | Phosphate compound containing |
| | 58 | Plant extract of undetermined constitution |
| | 59 | TOPICAL SUN OR RADIATION SCREENING, OR TANNING PREPARATIONS |
| | 61 | MANICURE OR PEDICURE COMPOSITIONS |
| | 62 | BLEACH FOR LIVE HAIR OR SKIN (E.G., PEROXIDES, ETC.) |
| | 63 | LIVE SKIN COLORANT CONTAINING |
| | 65 | ANTI-PERSPIRANTS OR PERSPIRATION DEODORANTS |
| | 69 | FACE OR BODY POWDERS FOR GROOMING, ADORNING, OR ABSORBING |
| | 70.1 | LIVE HAIR OR SCALP TREATING COMPOSITIONS (NONTHERAPEUTIC) |
| | 70.2 | Permanent waving or straightening |
| | 70.6 | Hair coloring (nondyeing) |
| | 70.8 | Astringent or sebum inhibiting |
| | 70.9 | UV protectant |
| | 70.11 | Polymer containing (nonsurfactant, natural or synthetic) |
| | 70.12 | Silicon containing |
| | 70.13 | Polysaccharide or derivative |
| | 70.14 | Protein or derivative |
| | 70.15 | Polyvinylpyrrolidone or copolymer thereof |
| | 70.16 | Poly(meth)acrylic acid, salt, or copolymer thereof |
| | 70.17 | Polyamine, polyamide, or derivatives thereof |
| | 70.19 | Two or more designated surfactant containing |
| | 70.21 | Amphoteric or zwitterionic surfactant containing |
| | 70.22 | Anionic surfactant containing |
| | 70.27 | Cationic surfactant containing |
| | 70.31 | Nonionic surfactant containing |
| | 73 | Shaving preparation |
| | 74 | Plant extract of undetermined constitution |
| | 75 | EMBALMING OR UNDERTAKING COMPOSITIONS |
| | 76.1 | DEODORANTS (NONBODY) |
| | 76.2 | Deodorizing substance is evaporable sublimable or gas (e.g., deodorization of air, aerosol spray compositions, etc.) |
| | 76.21 | For chemical reaction with odor producing material or gas evolving composition |
| | 76.3 | From a gel or solid matrix (e.g., retarded vaporization compositions, etc.) |
| | 76.5 | For application to waste materials, solid or liquid refuse or sewage |
| | 76.8 | With bio-affecting material (i.e., biocide or biostat) |
| | 77 | ADHESIVE TRAPPING COMPOSITIONS |
| | 78.01 | DIGESTIVE SYSTEM REGULATOR CONTAINING SOLID SYNTHETIC ORGANIC POLYMER AS DESIGNATED ORGANIC ACTIVE INGREDIENT (DOAI) (E.G., ANTI-DIARRHETIC, ANTICONSTIPATION, APPETITE SUPPRESSANT, LAXATIVE, ETC.): |
| | 78.02 | TOPICAL BODY PREPARATION CONTAINING SOLID SYNTHETIC ORGANIC POLYMER AS DESIGNATED ORGANIC ACTIVE INGREDIENT (DOAI) |
| | 78.03 | Skin cosmetic coating |
| | 78.04 | Ophthalmic preparation |
| | 78.05 | Anti-inflammatory or anti-irritant (e.g., anti-arthritic, etc.) |
| | 78.06 | Skin burn or open wound treatment |
| | 78.07 | Anti-infective |
| | 78.08 | SOLID SYNTHETIC ORGANIC POLYMER AS DESIGNATED ORGANIC ACTIVE INGREDIENT (DOAI) |
| | 78.09 | Anti-fouling composition (e.g., paints, etc.) |
| | 78.1 | Ion exchange resin |
| | 78.17 | Aftertreated polymer (e.g., grafting, blocking, etc.) |
| | 78.18 | Polymer derived from ethylenic monomers only |
| | 78.19 | Heterocyclic monomer |
| | 78.26 | Chemical treating agent contains element other than C, H, O, alkali, or alkaline earth metal |
| | 78.3 | Heterocyclic monomer |
| | 78.31 | Polymer from ethylenic monomers only |
| | 78.32 | Heterocyclic monomer |
| | 78.34 | Heavy metal containing monomer |
| | 78.35 | Nitrogen or sulfur containing monomer |
| | 78.36 | Nitrogen heterocycle |
| | 78.37 | Monomer contains oxygen |
| | 84 | BAITS, ATTRACTANTS, OR LURES (NON-FOOD) |
| | 85.1 | LYMPHOKINE |
| | 130.1 | IMMUNOGLOBULIN, ANTISERUM, ANTIBODY, OR ANTIBODY FRAGMENT, EXCEPT CONJUGATE OR COMPLEX OF THE SAME WITH NONIMMUNOGLOBULIN MATERIAL |
| | 131.1 | Anti-idiotypic |
| | 132.1 | Derived from transgenic multicellular eukaryote (e.g., plant, etc.) |
| | 133.1 | Structurally-modified antibody, immunoglobulin, or fragment thereof (e.g., chimeric, humanized, CDR-grafted, mutated, etc.) |
| | 135.1 | Single chain antibody |
| | 136.1 | Bispecific or bifunctional, or multispecific or multifunctional, antibody or fragment thereof |
| | 137.1 | Binds specifically-identified oligosaccharide structure |
| | 138.1 | Binds expression product or fragment thereof of cancer-related gene (e.g., oncogene, proto-oncogene, etc.) |
| | 139.1 | Binds antigen or epitope whose amino acid sequence is disclosed in whole or in part (e.g., binds specifically-identified amino acid sequence, etc.) |
| | 141.1 | Monoclonal antibody or fragment thereof (i.e., produced by any cloning technology) |
| | 142.1 | Human |
| | 143.1 | Binds receptor |
| | 144.1 | Receptor integral to or derived from a lymphocytic or lymphocytic-like cell (e.g., NK cell, etc.) |
| | 146.1 | Binds enzyme |
| | 147.1 | Binds virus or component thereof |
| | 150.1 | Binds bacterium or component thereof or substance produced by said bacterium |
| | 152.1 | Binds eukaryotic cell or component thereof or substance produced by said eukaryotic cell |
| | 157.1 | Derived from, or present in, food product (e.g., milk, colostrum, whey, eggs, etc.) |
| | 159.1 | Binds virus or component thereof |
| | 163.1 | Binds antigens of multiple bacterial species (e.g., multivalent antiserum that binds antigens of multiple bacterial species, etc.) |
| | 164.1 | Binds bacterium or component thereof or substance produced by said bacterium |
| | 165.1 | Staphylococcus or Streptococcus (e.g., pneumococcus or Streptococcus pneumoniae, Streptococcus mutans, etc.) |
| | 166.1 | Corynebacterium (e.g., Corynebacterium diphtheriae, etc.) |
| | 167.1 | Clostridium (e.g., Clostridium tetani, etc.) |
| | 168.1 | Mycobacterium |
| | 169.1 | Escherichia |
| | 170.1 | Pseudomonas |
| | 171.1 | Binds allergen or component thereof |
| | 172.1 | Binds eukaryotic cell or component thereof or substance produced by said eukaryotic cell (e.g., honey, etc.) |
| | 175.1 | Binds hapten, hapten-carrier complex, or specifically-identified chemical structure (e.g., drug, etc.) |
| | 176.1 | Free from infectious agents (e.g., viruses or bacteria removed or inactivated, etc.) |
| | 178.1 | CONJUGATE OR COMPLEX OF MONOCLONAL OR POLYCLONAL ANTIBODY, IMMUNOGLOBULIN, OR FRAGMENT THEREOF WITH NONIMMUNOGLOBULIN MATERIAL |
| | 179.1 | Conjugated via claimed linking group, bond, chelating agent, or coupling agent (e.g., conjugated to proteinaceous toxin via claimed linking group, bond, coupling agent, etc.) |
| | 180.1 | Conjugate includes potentiator or composition comprising conjugate includes potentiator |
| | 181.1 | Conjugated to nonproteinaceous bioaffecting compound (e.g., conjugated to cancer-treating drug, etc.) |
| | 182.1 | Conjugate includes potentiator; or composition comprising conjugate includes potentiator |
| | 183.1 | Conjugated to proteinaceous toxin or fragment thereof (e.g., conjugated to diphtheria toxin, Pseudomonas exotoxin, ricin, gelonin, abrin, etc.) |
| | 184.1 | ANTIGEN, EPITOPE, OR OTHER IMMUNOSPECIFIC IMMUNOEFFECTOR (E.G., IMMUNOSPECIFIC VACCINE, IMMUNOSPECIFIC STIMULATOR OF CELL-MEDIATED IMMUNITY, IMMUNOSPECIFIC TOLEROGEN, IMMUNOSPECIFIC IMMUNOSUPPRESSOR, ETC.) |
| | 185.1 | Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same |
| | 186.1 | Disclosed amino acid sequence derived from virus |
| | 190.1 | Disclosed amino acid sequence derived from bacterium (e.g., Mycoplasma, Anaplasma, etc.) |
| | 191.1 | Disclosed amino acid sequence derived from parasitic organism (e.g., Dirofilaria, Eimeria, Trichinella, etc.) |
| | 192.1 | Fusion protein or fusion polypeptide (i.e., expression product of gene fusion) |
| | 193.1 | Conjugate or complex |
| | 194.1 | Conjugated via claimed linking group, bond, or coupling agent |
| | 195.11 | Conjugate or complex includes hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or fragment thereof |
| | 196.11 | Conjugate or complex includes virus or componenet thereof |
| | 197.11 | Conjugate or complex includes bacterium or component thereof or substance produced by said bacterium |
| | 198.1 | Hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, neurotransmitter, or fragment thereof |
| | 199.1 | Recombinant virus encoding one or more heterologous proteins or fragments thereof |
| | 200.1 | Recombinant or stably-transformed bacterium encoding one or more heterologous proteins or fragments thereof |
| | 201.1 | Combination of viral and bacterial antigens (e.g., multivalent viral and bacterial vaccine, etc.) |
| | 202.1 | Combination of antigens from multiple viral species (e.g., multivalent viral vaccine, etc.) |
| | 203.1 | Combination of antigens from multiple bacterial species (e.g., multivalent bacterial vaccine, etc.) |
| | 204.1 | Virus or component thereof |
| | 205.1 | Reassortant or deletion mutant virus |
| | 207.1 | Retroviridae (e.g., feline leukemia virus, bovine leukemia virus, avian leukosis virus, equine infectious anemia virus, Rous sarcoma virus, HTLV-I, etc.) |
| | 209.1 | Orthomyxoviridae (e.g., influenza virus, fowl plague virus, etc.) |
| | 211.1 | Paramyxoviridae (e.g., parainfluenza virus, respiratory syncytial virus, rinderpest virus, Sendai virus, canine tracheobronchitis virus, turkey rhinotracheitis virus, etc.) |
| | 215.1 | Reoviridae (e.g., rotavirus, reovirus, orbivirus, avian proventriculitis virus, bluetongue virus, Colorado tick fever virus, etc.) |
| | 216.1 | Calciviridae or picornaviridae, except hepatitis A virus (e.g., foot-and- mouth disease virus (FMDV), coxsackievirus, echovirus, avian encephalomyelitis virus, Mengovirus, etc.) |
| | 221.1 | Coronaviridae (e.g., neonatal calf diarrhea virus, feline infectious peritonitis virus, canine coronavirus, etc.) |
| | 224.1 | Rhabdoviridae (e.g., rabies virus, vesicular stomatitis virus, etc.) |
| | 225.1 | Hepatitis virus (e.g., infectious canine hepatitis virus, duck hepatitis virus, mouse hepatitis virus, etc.) |
| | 226.1 | Hepatitis A virus |
| | 227.1 | Hepatitis B virus (e.g., hepatitis B surface antigen (HBsAg), pre-S region, hepatitis B core antigen (HBcAg), hepatitis B e-antigen, Dane particle, etc.) |
| | 228.1 | Non-A, non-B hepatitis virus or hepatitis C virus |
| | 230.1 | Cytomegalovirus, varicella or herpes zoster virus, or Epstein-Barr virus |
| | 231.1 | Herpes simplex virus (e.g., HSV-1, HSV-2, etc.) |
| | 232.1 | Poxviridae (e.g., smallpox virus, avian pox virus, fowlpox virus, rabbit myxoma virus, vaccinia virus, etc.) |
| | 234.1 | Bacterium or component thereof or substance produced by said bacterium (e.g., Legionella, Borrelia, Anaplasma, Shigella, etc.) |
| | 235.1 | Transposon mutant or deletion mutant bacterium (e.g., produced by transposon mutagenesis, etc.) |
| | 236.1 | Toxin or toxoid, except endotoxin (e.g., exotoxin, enterotoxin, etc.) |
| | 237.1 | Staphylococcus or Streptococcus |
| | 238.1 | Corynebacterium (e.g., Corynebacterium diphtheriae, etc.) |
| | 239.1 | Clostridium (e.g., Clostridium tetani, etc.) |
| | 240.1 | Bordetella (e.g., Bordetella pertussis, etc.) |
| | 241.1 | Escherichia (e.g., Escherichia coli, etc.) |
| | 242.1 | Pilus, fimbria, or adhesin |
| | 243.1 | Staphylococcus (e.g., Staphylococcus aureus, etc.) |
| | 244.1 | Streptococcus (e.g., Group B Streptococcus, pneumococcus or Streptococcus pneumoniae, etc.) |
| | 245.1 | Corynebacterium (e.g., Corynebacterium diphtheriae, etc.) |
| | 246.1 | Bacillus |
| | 247.1 | Clostridium (e.g., Clostridium tetani, Clostridium difficile, Clostridium perfringens, Clostridium botulinum, Clostridium chauvoei, etc.) |
| | 248.1 | Mycobacterium (e.g., Mycobacterium tuberculosis, Calmette-Guerin bacillus (i.e., BCG), etc.) |
| | 249.1 | Neisseria (e.g., Neisseria gonorrhoeae, etc.) |
| | 251.1 | Moraxella (e.g., Moraxella bovis, etc.) |
| | 252.1 | Brucella (e.g., Brucella abortus, Brucella canis, etc.) |
| | 253.1 | Bordetella (e.g., Bordetella bronchiseptica, etc.) |
| | 255.1 | Pasteurella (e.g., Pasteurella multocida, Pasteurella hemolytica, etc.) |
| | 256.1 | Hemophilus (e.g., Hemophilus influenzae, Hemophilus gallinarum, Hemophilus pleuropnemoniae, etc.) |
| | 257.1 | Escherichia (e.g., Escherichia coli, etc.) |
| | 258.1 | Salmonella (e.g., Salmonella typhimurium, etc.) |
| | 259.1 | Klebsiella (e.g., Klebsiella pneumoniae, etc.) |
| | 260.1 | Pseudomonas (e.g., Pseudomonas aeruginosa, etc.) |
| | 261.1 | Vibrio (e.g., Vibrio cholera, etc.) |
| | 262.1 | Treponema (e.g., Treponema hyodysenteriae, Treponema pallidum, etc.) |
| | 263.1 | Chlamydia (e.g., Chlamydia trachomatis, etc.) |
| | 264.1 | Mycoplasma |
| | 265.1 | Parasitic organism or component thereof or substance produced by said parasitic organism (e.g., Schistosoma, Dirofilaria, Trichinella, Fasciola, Ancylostoma, Ascaris, etc.) |
| | 266.1 | Component characterized by molecular weight |
| | 269.1 | Parasitic protozoan (e.g., Trypanosoma, Trichomonas, Leishmania, Entamoeba, etc.) |
| | 274.1 | Fungus, except allergen, or component thereof or substance produced by said fungus (e.g., Trichophyton, etc.) |
| | 275.1 | Allergen or component thereof (e.g., ragweed pollen, etc.) |
| | 277.1 | Cancer cell or component thereof |
| | 278.1 | NONSPECIFIC IMMUNOEFFECTOR, PER SE (E.G., ADJUVANT, NONSPECIFIC IMMUNOSTI- MULATOR, NONSPECIFIC IMMUNOPOTENTIATOR, NONSPECIFIC IMMUNOSUPPRESSOR, NON- SPECIFIC IMMUNOMODULATOR, ETC.); OR NONSPECIFIC IMMUNOEFFECTOR, STABILIZER, EMULSIFIER, PRESERVATIVE, CARRIER, OR OTHER ADDITIVE FOR A COMPOSITION CON- TAINING AN IMMUNOGLOBULIN, AN ANTISERUM, AN ANTIBODY, OR FRAGMENT THEREOF, AN ANTIGEN, AN EPITOPE, OR OTHER IMMUNOSPECIFIC IMMUNOEFFECTOR |
| | 280.1 | Synthetic polymer or copolymer |
| | 281.1 | Virus (e.g., interferon-inducing virus, etc.) |
| | 282.1 | Bacterium or component thereof or substance produced by said bacterium |
| | 283.1 | Lipid or oil |
| | 93.1 | WHOLE LIVE MICRO-ORGANISM, CELL, OR VIRUS CONTAINING |
| | 93.2 | Genetically modified micro-organism, cell, or virus (e.g., transformed, fused, hybrid, etc.) |
| | 93.3 | Intentional mixture of two or more micro-organisms, cells, or viruses of different genera |
| | 93.4 | Bacteria or actinomycetales |
| | 93.41 | Clostridium |
| | 93.42 | Staphylococcus |
| | 93.43 | Streptomyces |
| | 93.44 | Streptococcus |
| | 93.45 | Lactobacillus or Pediococcus or Leuconostoc |
| | 93.46 | Bacillus |
| | 93.47 | Pseudomonas |
| | 93.48 | Enterobacteriaceae |
| | 93.5 | Fungus |
| | 93.6 | Virus or bacteriophage |
| | 93.7 | Animal or plant cell |
| | 94.1 | ENZYME OR COENZYME CONTAINING |
| | 94.2 | Multienzyme complexes or mixtures of enzymes |
| | 94.3 | Stabilized enzymes or enzymes complexed with nonenzyme (e.g., liposomes, etc.) |
| | 94.4 | Oxidoreductases (1. ) (e.g., catalase, dehydrogenases, reductases, etc.) |
| | 94.5 | Transferases (2. ), Lyase (4.), Isomerase (5.), Ligase (6.) |
| | 94.6 | Hydrolases (3. ) (e.g., urease, lipase, asparaginase, muramidase, etc.) |
| | 94.61 | Acting on glycosyl compound (3.2) (e.g., glycosidases lysozyme, nucleosidases, cellulase, etc.) |
| | 94.63 | Acting on peptide bonds (3.4) (e.g., urokinease, etc.) |
| | 94.64 | Serine proteinases (3.4.21) (e.g., trypsin, chymotrypsin, plasmin, thrombin, elastase, kallikrein, fibrinolysin, streptokinease, etc.) |
| | 94.65 | SH-proteinases (3.4.22) (e.g., papain, chymopapain, bromelains, ficin, etc.) |
| | 94.66 | Acid proteinases (3.4.23) (e.g., pepsin, renin, chymosin, etc.) |
| | 94.67 | Metalloproteinases (3.4.24) (e.g., collagenase, snake venom zinc proteinase, etc.) |
| | 520 | EXTRACT, BODY FLUID, OR CELLULAR MATERIAL OF UNDETERMINED CONSTITUTION DERIVED FROM ANIMAL IS ACTIVE INGREDIENT |
| | 522 | Separated animal oil or solidified form thereof derived from animal flesh and other than from liver or dairy type |
| | 523 | Fish oil or solidified form thereof |
| | 524 | Whale or porpoise oil or solidified form thereof |
| | 525 | Skunk, musk, or mink oil or solidified form thereof |
| | 526 | Lard, rind, or tallow |
| | 528 | Bile, bile acid, bile salt, amniotic fluid, or ascitic fluid |
| | 529 | Blood |
| | 535 | Milk or colostrum (e.g., butter, whey, etc.) |
| | 537 | Body fluid or exudate or transudate other than snake venom, feces, urine, or semen (e.g., lymph, saliva, honey, royal jelly, digestive juice, etc.) |
| | 538 | Derived from arthropod (e.g., insect, spider, crustacea, etc.) |
| | 542 | Derived from snake (e.g, venom, etc.) |
| | 543 | Waste or feces (e.g., slaughterhouse offal, chicken feet, horn, hair, hide, urine, etc.) |
| | 547 | Derived from mollusk |
| | 548 | Derived from musculoskeletal system, other than cardiac muscle (e.g., cartilage, muscle, etc.) |
| | 550 | Digestive system (e.g., salivary gland, etc.) |
| | 557 | Respiratory system (e.g., lung, etc.) |
| | 558 | Urogenital system (e.g., kidney, etc.) |
| | 559 | Genitalia (e.g., ovary, uterus, prostate, testis, etc.) |
| | 561 | Germ cell (e.g., ovum, spermatozoa, etc.) |
| | 562 | Endocrine system, other than the thymus gland (e.g., parathyroid gland, etc.) |
| | 569 | Cardiovascular system, other than umbilical artery or vein (e.g., blood vessel, heart, cardiac muscle, etc.) |
| | 570 | Nervous system (e.g., brain, nerve, etc.) |
| | 571 | Sense organ (e.g., eye, taste bud, etc.) |
| | 572 | Tissue, other than lymphoid tissue (e.g., connective, etc.) |
| | 577 | Hemic or immune system (e.g., hematopoietic system, bone marrow cells, etc.) |
